Housing Discrimination Increases Cancer Death Risk Among Young Patients

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- Children, teens and young adults have a higher risk of dying from cancer if they were raised in a neighborhood that’s been historically subjected to discriminatory housing practices.

Young cancer patients have a 62% increased risk of dying if they live in a previously “redlined” residential area, researchers reported in a study published Jan. 27 in the journal Cancer.

Even after adjusting for other factors, the risk of cancer death remains 32% higher among young people from redlined neighborhoods, researchers found.

“Our study names racism as a potential driver of outcomes for young patients with cancer,” lead researcher Dr. Kristine Karvonen, a pediatric hematologist/oncologist with the Fred Hutchinson Cancer Center in Seattle, said in a news release.

The practice of redlining involved denying mortgages and lending to people of color, resulting in segregation and economic disadvantage.

Maps drawn up in the 1920s and 1930s literally highlighted neighborhoods in red ink and declared them “hazardous” for lending due to their racial makeup.

Housing reform laws passed in the 1960s and 1970s made the practice illegal, but the effects of this discrimination have echoed down over the decades.

Previous studies have linked redlining to higher risk of cancer death for adults, but this is the first to examine the potential effects of housing discrimination on younger people’s chances against cancer, researchers said.

For the study, researchers analyzed data on more than 4,300 people younger than 40 who were diagnosed with cancer in the Washington cities of Seattle and Tacoma.

Using redlining maps, the team figured out which patients had been raised in an area subjected to housing discrimination.

The five-year survival rate of young cancer patients from a redlined neighborhood was 85%, compared to more than 90% for those living elsewhere, results show.

Similarly, the 10-year survival rate was 81% for those from redlined neighborhoods compared with 88% elsewhere.

“This study agrees with previous research that living in an area that was previously redlined nearly a century ago is associated with poor outcomes for patients with cancer today and adds young patients with cancer as a population at risk,” Karvonen said.

The next step in research will be to figure out why historic redlining influences today’s cancer risk, Karvonen said. With that knowledge, steps can be taken to improve the cancer treatment and prevention among people from these neighborhoods.

Sources

  • American Cancer Society, news release, Jan. 27, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-01-30 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords